Symbol="XENE"
AssetType="Common Stock"
Name="Xenon Pharmaceuticals Inc"
Description="Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat patients with neurological disorders in Canada. The company is headquartered in Burnaby, Canada."
CIK="1582313"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="200 - 3650 GILMORE WAY, BURNABY, BC, CA"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="2281251000"
EBITDA="-159223008"
PERatio="None"
PEGRatio="-0.06"
BookValue="10.88"
DividendPerShare="0"
DividendYield="0"
EPS="-2.35"
RevenuePerShareTTM="0.011"
ProfitMargin="0"
OperatingMarginTTM="-240.76"
ReturnOnAssetsTTM="-0.157"
ReturnOnEquityTTM="-0.24"
RevenueTTM="668000"
GrossProfitTTM="-96333000"
DilutedEPSTTM="-2.35"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-1"
AnalystTargetPrice="52.31"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="181.44"
PriceToBookRatio="3.217"
EVToRevenue="136.05"
EVToEBITDA="-16.41"
Beta="1.385"
num_52WeekHigh="43.75"
num_52WeekLow="31.79"
num_50DayMovingAverage="39.13"
num_200DayMovingAverage="37.82"
SharesOutstanding="63562000"
DividendDate="None"
ExDividendDate="None"
symbol="XENE"
open="35.65"
high="36.18"
low="35.34"
price="35.35"
volume="348108.00"
latest_trading_day="2023-08-08"
previous_close="35.51"
change="-0.16"
change_percent="-0.4506%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="47"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="53"
Volume_recent_avg="358241"
Change_recent_avg="0.02"
Delta_recent_avg="1.39"
Variance_recent_avg="0.69"
Change_ratio_recent_avg="0.04"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="53"
Aroon_momentum_negative="47"
image_negative_thumbnail_id_1="1125"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0158.jpeg"
image_negative_thumbnail_id_2="1137"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0170.jpeg"
image_neutral_thumbnail_id_1="566"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0033.jpeg"
image_neutral_thumbnail_id_2="557"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0042.jpeg"
image_positive_thumbnail_id_1="998"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0160.jpeg"
image_positive_thumbnail_id_2="666"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0042.jpeg"
image_professor_thumbnail_id_1="1178"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0012.jpeg"
image_professor_thumbnail_id_2="1192"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0026.jpeg"
